S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.19 (+0.81%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.19 (+0.81%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.19 (+0.81%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.19 (+0.81%)
NFLX   187.44 (+0.58%)
NASDAQ:PRAX

Praxis Precision Medicines Earnings Date, Estimates, & History

$9.82
-0.89 (-8.31%)
(As of 05/23/2022 04:00 PM ET)
Add
Compare
Today's Range
$9.77
$10.88
50-Day Range
$7.39
$11.87
52-Week Range
$7.25
$23.56
Volume
178,965 shs
Average Volume
268,906 shs
Market Capitalization
$446.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.04

Earnings Summary

Upcoming
Earnings Date
Aug. 15Estimated
Actual EPS
(May. 9)
-$1.51 Missed By -$0.22
Consensus EPS
(May. 9)
-$1.29
Last Year's Q2 EPS
(5/11/2021)
-$0.71
Skip Charts & View Estimated and Actual Earnings Data

Praxis Precision Medicines Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Praxis Precision Medicines Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Praxis Precision Medicines (NASDAQ:PRAX) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20223($1.41)($1.18)($1.27)
Q2 20223($1.30)($1.13)($1.20)
Q3 20223($1.20)($0.96)($1.11)
Q4 20223($1.20)($0.84)($1.04)
FY 202212($5.11)($4.11)($4.62)
Q1 20233($1.21)($0.76)($1.02)
Q2 20233($1.16)$0.72($0.51)
Q3 20233($1.12)($0.73)($0.94)
Q4 20233($1.13)($0.74)($0.93)
FY 202312($4.62)($1.51)($3.41)

PRAX Earnings Information

Praxis Precision Medicines last announced its quarterly earnings data on May 9th, 2022. The reported ($1.51) earnings per share for the quarter, missing analysts' consensus estimates of ($1.29) by $0.22. Praxis Precision Medicines has generated ($4.69) earnings per share over the last year (($4.69) diluted earnings per share). Earnings for Praxis Precision Medicines are expected to grow in the coming year, from ($5.47) to ($5.03) per share. Praxis Precision Medicines has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 15th, 2022 based off prior year's report dates.

Praxis Precision Medicines (NASDAQ:PRAX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
8/15/2022
(Estimated)
        
5/9/20223/31/2022($1.29)($1.51)($0.22)      
2/28/2022Q4 2021($1.08)($1.30)($0.22)($1.30)    
11/3/20219/30/2021($0.93)($1.00)($0.07)($1.00)  
8/16/20216/30/2021($0.68)($0.88)($0.20)($0.88)
5/11/2021Q1($0.7430)($0.71)+$0.0330($0.71)
3/16/2021Q4($0.3750)($0.87)($0.4950)($0.87)  
11/23/2020Q3 2020($12.10)($12.10)($12.10)
(Earnings results data provided by Zacks Investment Research)












Praxis Precision Medicines (NASDAQ:PRAX) Earnings Frequently Asked Questions

When is Praxis Precision Medicines's earnings date?

Praxis Precision Medicines has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 15th, 2022 based off last year's report dates. Learn more on PRAX's earnings history.

Did Praxis Precision Medicines beat their earnings estimates last quarter?

In the previous quarter, Praxis Precision Medicines (NASDAQ:PRAX) missed the analysts' consensus estimate of ($1.29) by $0.22 with a reported earnings per share (EPS) of ($1.51). Learn more on analysts' earnings estimate vs. PRAX's actual earnings.

How can I listen to Praxis Precision Medicines's earnings conference call?

The conference call for Praxis Precision Medicines's latest earnings report can be listened to online. Listen to Conference Call

How can I read Praxis Precision Medicines's conference call transcript?

The conference call transcript for Praxis Precision Medicines's latest earnings report can be read online. Read Transcript

How can I view Praxis Precision Medicines's earnings report?

Praxis Precision Medicines's earnings report can be found in their filing with the SEC. View SEC filing

How much profit does Praxis Precision Medicines generate each year?

Praxis Precision Medicines (NASDAQ:PRAX) has a recorded net income of -$167.06 million. PRAX has generated -$4.69 earnings per share over the last four quarters.

What is Praxis Precision Medicines's EPS forecast for next year?

Praxis Precision Medicines's earnings are expected to grow from ($5.47) per share to ($5.03) per share in the next year.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.